Lv11
22 积分 2021-08-13 加入
First-in-human study of the antibody DR5 agonist DS-8273a in patients with advanced solid tumors
2小时前
已完结
A phase separation-fortified bi-specific adaptor for conditional tumor killing
5小时前
已完结
Combination of multivalent DR5 receptor clustering agonists and histone deacetylase inhibitors for treatment of colon cancer
4天前
已完结
DNA-based delivery of anti-DR5 Nanobodies improves exposure and anti-tumor efficacy over protein-based administration
5天前
已完结
Compact clustering of highly oligomerized anti-DR5 nanobodies effectively drives apoptotic cancer cell death, significantly suppressing tumor growth
5天前
已完结
LBY135, a novel anti‐DR5 agonistic antibody induces tumor cell–specific cytotoxic activity in human colon tumor cell lines and xenografts
5天前
已完结
Small-molecule activation of the TRAIL receptor DR5 in human cancer cells
6天前
已完结
A phase separation-fortified bi-specific adaptor for conditional tumor killing
6天前
已完结
AFP-specific T cell receptors with fine-tuning affinity induce durable tumor remission in mice and acquire pan-HLA-A∗02 recognition
7天前
已完结
DR5/WDR12 balances p65 stability promoting sunitinib resistance in renal cell carcinoma
8天前
已完结
皖公网安备34019202002308
